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Abstract.  Anchoring  fibrils are specialized fibrous 
structures found in the subbasal lamina underlying 
epithelia of several external tissues.  Based upon their 
sensitivity to collagenase and the similarity in banding 
pattern to artificially created segment-long spacing 
crystallites (SLS) of collagens,  several authors have 
suggested that anchoring  fibrils are lateral aggregates 
of collagenous macromolecules. We recently reported 
the similarity  in length and banding pattern of anchor- 
ing fibrils to type VII collagen SLS crystallites. We 
now report the construction and characterization  of a 
murine monoclonal antibody specific for type VII col- 
lagen.  The epitope identified by this antibody has been 
mapped to the carboxyl terminus of the major helical 
domain of this molecule. The presence of type VII 
collagen as detected by indirect immunofluorescence in 
a variety of tissues corresponds exactly with ultra- 
structural observations of anchoring  fibrils.  Ultrastruc- 
tural immunolocalization of type VII collagen using a 
5-nm colloidal gold-conjugated second antibody 
demonstrates metal deposition upon anchoring fibrils 
at both ends of these structures,  as predicted by the 
location of the epitope on type VII collagen.  Type VII 
collagen is synthesized by primary cultures of amniotic 
epithelial cells. It is also produced by KB cells (an 
epidermoid carcinoma cell line) and WISH (a trans- 
formed amniotic cell line). 
CHORING fibrils are specialized  fibrous structures  (5, 
29) found within the subbasal lamina in human and 
rat oral mucosa, amphibian  skin and notocord, hu- 
man and rat gingiva, human cervical mucosa, mouse uterus, 
and human vaginal mucosa, and also along Schwarm cells in 
unmylelinated nerve fibers in human skin (21). Ultrastructur- 
ally, they have a centrosymmetric banding pattern suggesting 
that they are composed of an aligned lateral aggregate of in- 
dividual anti-parallel fibrous subunits.  The absolute length 
of these structures is difficult to determine because they un- 
dulate in and out of the plane of section, but the longest an- 
choring  fibrils thus far documented approximate  750 nm in 
length (5). The presumed function of the anchoring  fibril is 
to secure the lamina densa to the underlying  connective tis- 
sue matrix  by physical entrapment  of major collagen  fibers 
between the  lamina  densa  and  the  anchoring  fibril.  The 
chemical nature of anchoring  fibrils is unknown.  Similarity 
of banding  pattern of observed anchoring  fibrils  with that 
of artificially  aggregated  segment-long  spacing  crystallites 
(SLS crystallites) ~ of collagens  (32) and their sensitivity  to 
destruction  by bacterial  collagenase  (19) suggest  that  ag- 
gregates of collagen may be the major structural  component 
of the anchoring  fibril.  This concept was further strength- 
ened by the observation that  both the dimensions  and  the 
1. Abbreviations used in this paper: ELISA, enzyme-linked immunosorbent 
assay; SLS crystallites, segment-long spacing crystallites. 
banding  pattern of anchoring  fibrils  strongly  resemble di- 
meric type VII collagen SLS crystaUites (8). In this report, 
we confirm the identification of type VII collagen within the 
anchoring  fibrils. 
The importance of anchoring fibrils to the structural stabil- 
ity of skin  is  strongly  supported by the  observation that 
patients  lacking  anchoring  fibrils,  as determined by ultra- 
structural  visualization,  demonstrate the phenotype of epi- 
dermolysis bullosa dystrophica-recessive (3). These patients 
suffer extensive cutaneous blistering resulting from a separa- 
tion  of the dermis from the epidermis along  the subbasal 
lamina. 
Type VII collagen has recently been described (2, 28). Af- 
ter solubilization  from amnion  by limited proteolysis using 
pepsin, the type VII molecule is visualized by transmission 
electron  microscopy after rotary  shadowing  as  a  780-rim 
dimer of two identical molecules, each 424 nm in length as- 
sociated through  a 60-nm overlap  of the triple-helical  do- 
mains stabilized by disulfide bonds (28). Re-exposure of this 
molecule to pepsin under nondenaturing  conditions cleaves 
each dimer into three components:  two fragments denoted as 
P2, each  174 nm in length  (which  represent the carboxyl- 
terminal  portions of the molecules), and a third peptide de- 
noted as (P1)2,440 nm in length, which contains two 250-nm 
long peptides held together by disulfide bonds within a 60- 
nm overlap  (see Fig.  9).  Comparisons of the banding  pat- 
terns of SLS crystallites made from type VII collagen dimers 
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respond to the region of anchoring fibrils at the site of inser- 
tion into the basal lamina and the (P1)2 peptides correspond 
to the central region (8). 
Materials and Methods 
Preparation of Collagens 
Type VII collagen and peptides P1 and P2 were prepared as previously de- 
scribed (2, 28).  Collagen types I, Ill,  and V  were prepared from human 
amnion as detailed previously (6). Type II collagen was prepared from neo- 
natal human femoral head cartilage as described (7). Collagen type IV was 
obtained from human placenta (33) and type VI was a generous gift from 
Dr.  Robert Glanville (The Shriners Hospital for Crippled Children). 
Monoclonal  A n tibody  Production 
A/J mice (Jackson Laboratories, Bar Harbor,  ME) were immunized with 
100 p.g of human type VII collagen emulsified in complete Freund's adju- 
vant. 2 wk later mice were boosted on three consecutive days with 200 ~tg 
of human type VII collagen, and spleen cells were fused with the myeloma 
cell line P3-NS1/1-Ag4-1  (22) on the fourth day, according to previously de- 
scribed methods (18, 33). Hybridomas were screened for the production of 
antibody by the enzyme-linked immunosorbent assay (ELISA) and by in- 
direct immunofluorescence, and selected colonies were cloned by limiting 
dilution. 
Antibody was collected from selected hybridoma clones either in the 
form of spent tissue culture medium or as ascites from BALB/c x A/J hy- 
brid mice, pristane primed, and injected with at least 107 hybridoma cells. 
For some experiments, ascites antibody was purified using DEAE Atii-gel 
Blue  chromatography  (Bio-Rad  Laboratories,  Richmond,  CA),  Protein 
A-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ),  or type VII- 
coupled Sepharose. 
ELISA 
According to established methods (11), microtiter plates were coated with 
antigen (1-10 p.g/ml) in bicarbonate-carbonate buffer, pH 9.6, overnight at 
4°C, and were washed with phosphate-buffered saline (PBS)-0.05 % Tween 
20 to remove unadsorbed antigen.  Hybridoma supernatants were diluted 
with PBS-0.05% Tween 20 and allowed to react with antigen-coated wells 
for 3 h at room temperature. After washing to remove unbound antibody, 
alkaline phosphatase-conjugated anti-mouse IgG (Sigma Chemical Co., St. 
Louis, MO) diluted in PBS-0.05 % Tween 20 was incubated in the wells for 
2  h,  and  after  washing to  remove unbound second antibody,  substrate 
(p-nitrophenyl phosphate; Sigma Chemical Co.) was added.  Absorbance 
was measured at 405 nm using Titertek Multiskan (Flow Laboratories, Inc., 
McLean, VA). 
To screen hybridoma supernatants, type VII collagen was used to coat 
ELISA wells. In studies to determine cross-reactivity of the antibody with 
other collagens, types I-VII collagens were used as antigens. 
To test the thermal stability of the antigenic site, type VII collagen was 
heated for 15 min at various temperatures, cooled rapidly in ice, and used 
to coat ELISA wells. Alternatively, 0.1 M 2-mercaptoethanol was added be- 
fore heating to examine the effect of disulfide bonds on the stability of the 
antigenic site. 
In experiments to determine the sensitivity of the antigenic site to Clos- 
tridial collagenase (Advance Biofactures, Lynbrook, NY), antigen-coated 
wells were incubated with collagenase in 50 mM Tris-HCl, pH 7.4, contain- 
ing 10  -3 M N-ethylmaleimide and 10  -3 M CaCI2 for 30 min at 30°C. After 
washing, the binding of antibody was tested as above. 
Inhibition of antibody binding of type VII collagen was tested by incubat- 
ing varying amounts of type VII collagen with a fixed amount of antibody 
and then incubating the mixture on type VII-coated ELISA wells. 
Immunofluorescence 
Tissues were frozen in liquid nitrogen, and 8-I.tm sections were cut using 
an American Optical histostat microtome at -28°C. Sections were air dried 
for 30 min and fixed in cold acetone for 10 min. After washing in PBS, sec- 
tions were incubated with hybridoma supernatant for 2-3 h at room temper- 
ature, washed in PBS, and were then incubated with fluorescein-conjugated 
anti-mouse IgG (Sigma Chemical Co., St.  Louis, MO) for 30 rain. After 
washing, the sections were covered with 90%  glycerol in PBS and were 
viewed using a Zeiss Photomicroscope III. Cell cultures (primary cultures 
of amniocytes and fibroblasts and established lines KB [10],  WISH [15], 
HT1080 [12],  and FL [30]  from the American Type Culture Collection, 
Rockville, MD) grown on glass slides were fixed either in acetone or 2 % 
paraformaldehyde, and were then tested as above. 
Visualization of  Antigen  -Antibody Complexes 
Purified antibody was incubated in approximately equimolar concentration 
with type VII collagen overnight at 4°C in 0.2 M  NH4HCO3, pH 7.8. This 
mixture was then diluted with glycerol, sprayed, and rotary shadowed as 
previously described (9). 
Immunoelectron Microscopy 
En Bloc Labeling. Neonatal foreskin was obtained within 10 min after cir- 
cumcision, and sliced into strips (which all included epithelium) "~0.5-1 
mm in thickness with a double-edged razor blade. Tissue was then washed 
four times for 2 h at 4°C in 25 ml PBS, pH 7.4. The primary antibody was 
diluted 1:5 in PBS to 2 rnl and incubated with the tissue at 4°C for 7-15 h. 
Samples were extensively rinsed in at least four changes of PBS at 4°C for 
a minimum of 7 h. The samples were then incubated with 5-nm gold con- 
jugated to goat anti-mouse IgG (Jannsen Pharmaceuticals, Piscataway, NJ) 
diluted 1:2 in 1.0% BSA Buffer (20 mM Tris-HCl, 0.9%  NaCI,  1 mg/ml 
BSA,  20 mM NAN3),  pH  8.0,  for 5-15  h.  The incubated samples were 
washed in PBS as above and then rinsed in 0.1 M sodium cacodylate buffer, 
pH 7.4, three times for 15 min. Rinsed samples were fixed in cacodylate- 
buffered Karnovsky's fix (20) for 60 min at 4°C, rinsed in buffer three times 
for 15 min per rinse at 4°C, and finally fixed in 1% OsO4 in cacodylate for 
60 min at 4°C. Fixed samples were rinsed in buffer three times for 15 min 
each time at 4°C, and dehydrated at room temperature through 30, 50, 70, 
90, 95, and finally 100% ethanol. After two more changes of 100% ethanol 
over 30 min, samples were washed in 100%  propylene oxide three times 
for 30 rain each wash. Specimens were infiltrated with Spurr's epoxy (hard 
formula) embedded so as to obtain cross sections of epithelium and poly- 
merized at  70°C  overnight.  60-90-nm sections were  cut on a  Reichert 
Ultracut E Ultramicrotome and mounted on 2  x  l-ram formvar-coated slot 
grids. Grids were stained in 2% uranyl acetate in 50% ethanol for 15 min, 
and Reynold's lead citrate (31) for 60 s. 
Section Surface Labeling of Lowicryl K4M-embedded  Samples. Sam- 
ples were fixed in 0.1 M  phosphate-buffered picric acid/paraformaldehyde 
(35) on ice for 30 min. Samples were then rinsed in 0.1 M phosphate buffer 
over a  15-min period, then in 0.15 M Tris-HCl, pH 7.4, and again in phos- 
phate  buffer.  Samples  were  then  dehydrated  on  ice  from  30  to  100% 
CH3CH2OH, then infiltrated in Lowicryl K4M (13),  embedded in BEEM 
capsules so as to obtain cross sections of epithelium, and polymerized over- 
night at 4°C under ultraviolet (UV) light, then for an additional 2 d at am- 
bient temperature. 90-110-nm thick ultrathin sections were cut and mounted 
on formvar-coated 2  x  1-mm Pd slot grids. Grids supporting sections were 
floated on two pools of twice-distilled H20 over 10 min, for  15 min on a 
pool of 0.1% BSA buffer, pH 7.5, supplemented with 5% normal goat serum 
(total  volume 300 Ixl) on a parafilm sheet for 120 min at ambient tempera- 
ture. Grids were then washed quickly in BSA buffer, pH 7.5, twice in PBS, 
then again in BSA buffer.  The grids were floated section-side down on 300- 
I.tl drops of 5-nm colloidal gold-conjugated goat anti-mouse IgG diluted 1:3 
in 0.1% BSA buffer, pH 8.0, for 60 min at ambient temperature on parafilm 
in a covered petri dish, using moist filter paper to prevent evaporation. After 
incubation in gold complex, the grids were again floated on pools of BSA 
buffer and PBS as above, then on pools of twice-distilled water, and dried. 
Grids containing sections were then exposed to 0.1  M  phosphate-buffered 
1% OsO4 vapors, stained in a 2%  uranyl acetate in 50%  CH3CH2OH for 
15 min, and in Reynold's (31) lead citrate for  15 min before examination. 
Specimens prepared by either technique were then examined at 60-80 kV 
using a 30-I.tm objective aperture with a Philips 410 L.S. transmission elec- 
tron microscope. Magnification was calculated based on a carbon grating 
replica having 2,160 crossed lines per mm (Ernest E  Fullam, Inc., Schenec- 
tady, NY;  cat No.  10021). 
Results 
Antibody Characterization 
Hybridomas resulting from the fusion of spleen cells from 
type VII immunized mice with the myeloma line were cloned 
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A4o5  nln* 
-collagenase  +collagenase 
Anti-type VII (against type VII) 
Anti-type VII (against P1 + P2) 
Anti-type IV (against type IV) 
Anti-type II (against type II) 
Anti-NP32 (against crude NP) 
Anti-NP161 (against crude NP) 
PBS (against type VII) 
0.810 (100%)  0.180  (0%) 
0.15  (0%)  0.130  (0%) 
0.790 (100%)  0.180  (0%) 
0.625 (100%)  0.100  (0%) 
0.390 (lOO%)  0.380  (95%) 
0.375 (100%)  0.375 (100%) 
0.180  0.181 
* Values are averages  of five independent determinations. 
and screened for antigen binding by the ELISA. Immuno- 
positive clones were then tested for the sensitivity of anti- 
body binding to digestion of the substrate with clostridial 
collagenase. The reactivity of a monoclonal antibody to type 
IV (33) collagen before and after substrate collagenase diges- 
tion and the reactivity of a monoclonal antibody to type II 
(18) collagen before and after collagenase digestion of the 
substrate were used to demonstrate coUagenase activity. The 
reactivity  of two  monoclonal  antibodies  (anti-NP32  and 
anti-NPl61)  (16) to noncollagen matrix proteins before and 
after collagenase digestion of the substrate were used to de- 
tect the activity of noncollagen-specific proteases in the col- 
lagenase preparations.  The reactivity of the anti-type VII 
monoclonal antibody as well as the anti-type IV and anti- 
type II antibodies are completely susceptible to collagenase 
digestion of their respective substrates (Table I). Collagenase 
digestion  of the  substrate  of anti-NP32  and  anti-NP161 
shows no significant diminution of reactivity. The results in- 
dicate that the anti-type VII collagen epitope resides within 
or very near a triple-helical sequence. 
The ELISA reactivity of the anti-type VII monoclonal an- 
tibody can be fully inhibited by preincubation of the antibody 
with purified antigen.  At a  1:8,000  dilution of ascites anti- 
body, 2.5  llg of purified type VH collagen produces 100% 
inhibition as indicated in Fig  1. 
Thermal stability of the epitope was tested by preincubat- 
ing the antigen at 22, 40, 60, 80, and 100°C followed by rapid 
cooling and the ELISA (Fig. 2). Full activity is observed at 
22  and 40°C  with a  gradual decrease in activity to back- 
ground levels at  100°C.  Inclusion of 2-mercaptoethanol in 
the incubation mixture causes a complete loss of reactivity 
above 40°C. An approximate 50 % loss in activity is observed 
1 0  0  even at 22°C.  No equivalent reduction in reactivity is seen 
for type HI collagen in the presence or absence of 2-mercap- 
toethanol at 22°C  using an anti-type HI monoclonal anti- 
body. These experiments indicate that disulfide bonds are in- 
volved in the  stability of the  type VII epitope.  Once the 
7 5  disulfide bonds have been broken, reactivity is not regained 
above the denaturation temperature of the triple helix. These 
results suggest that the thermal stability of the epitope is de- 
pendent upon both an intact disulfide bond and the triple- 
helical conformation. Since interchain disulfide bonds have 
Z~  5 0  not  been  observed within  the  triple-helical  structure,  the  ,o !  O-2-Me 
= 
2  o  o.s  ~'  ~o 
40  ~  100  all~ 
i 
I  I  I  i 
0  1  2  3  4 
log  ng  TYPE  VII 
Figure 1.  Competitive inhibition of monoclonal antibody binding 
to antigen with purified type VII collagen.  Preincubation  of the 
anti-type VII monoclonal antibody with type VII collagen at vari- 
ous concentrations inhibits antibody binding to antigen as measured 
by the ELISA. Maximal inhibition was observed at 2.5 lig. The an- 
tibody solution is a 1:8,000 dilution of ascites. Type VII collagen 
concentration  was determined  by amino acid analysis. 
TEMPERATURE  *C 
Figure 2.  The effect of temperature and disulfide bond reduction 
upon the reactivity of the monoclonal antibody for type VII colla- 
gen. Antibody binding occurs at temperatures up to 40°C in the ab- 
sence of 2-mercaptoethanol  (2-Me) but is greatly reduced even at 
22°C  when the disulfide bonds of the substrate  are dissociated. 
Binding of a type m-specific monoctonal antibody to type HI colla- 
gen is unaffected by disulfide bond  reduction  but  is sensitive to 
denaturation of the substrate. Conjugate binding in the absence of 
first antibody indicates background absorbance (PBS). All ELISAs 
were performed as described  in Materials  and Methods. 
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Figure 4. The relationship of the antibody binding site to molecular 
length. Antibody-antigen complexes were visualized after rotary 
shadowing and the positions of antibody molecules were measured 
relevant to the distance to the  nearest molecular end (,,).  Only 
fully  distended,  non-overlapping dimeric  molecules were  mea- 
sured.  Any antibody touching an appropriate collagen molecule 
was scored. The total molecular lengths were also tallied (t~). 60 
molecules were measured. Greater than 70% of the observed bind- 
ing events occurred within 10 nm of the carboxyl termini. 
Figure 3. Transmission electron microscopical visualization of the 
monoclonal antibody-type VII collagen complex after rotary shad- 
owing. The anti-type VII collagen monoclonal antibody is shown 
to bind'the carboxyl-terminal ends of type VII dimers. Molecules 
with antibody at both termini are frequently seen (A, C; schemati- 
cally represented in B). Bivalent binding of both ends by a single 
antibody is also observed (D). 
results suggest that the epitope is near the boundary between 
a triple-helical and a globular domain. 
Redigestion of type VII collagen with pepsin under native 
conditions converts the type VII dimer to a dimer of P1 pep- 
tides and to P2 (2). Both the P1 dimer and P2 are indepen- 
dently disulfide bonded (28). Neither of these peptides is im- 
munoreactive by the ELISA (Table I). Proteolytic activity of 
pepsin occurs at a triple-helical disruption between the P1 
and P2 portions of the molecule and may also occur within 
non-triple-helical regions at the amino and/or carboxyl ter- 
mini. Therefore, the data indicate that the epitope resides ei- 
ther within a non-triple-helical region at either end of the 
molecule or at the internal pepsin site. 
The position of the epitope was demonstrated by visualiz- 
ing the antibody-antigen complex by transmission electron 
microscopy after rotary shadowing. As shown in Figs. 3 and 
4, antibody binds specifically to the carboxyl termini of the 
type VII dimer. 
Antibody Specificity 
The reactivity of the anti-type VII collagen antibody was 
tested versus human collagen types I-VII by ELISA (Table 
II). No reactivity above background levels was detected for 
any collagen type other than VII. The specificity of the anti- 
body was further demonstrated by indirect immunofluores- 
cence. Crisp, brilliant fluorescence is observed only at the 
basement membrane zone of the anmiotic epithelial base- 
ment membrane and the zone underlying the basement mem- 
brane of the dermal-epidermal junction of skin (Fig. 5). No 
staining of the type IV-containing basement membranes sur- 
rounding the vasculature and adnexal structures of skin nor 
the trophoblastic membranes of chorioamnion is observed. 
Likewise,  neither placenta nor muscle are  stained.  Addi- 
tional staining of these tissues and of elastic cartilage is not 
revealed by pretreatment of the tissue with acetic acid (25), 
pepsin (37), or hyaluronidase (18) (data not shown).  These 
observations indicate that the antibody recognizes an epitope 
specific to certain basement membrane zones. No staining is 
observed for any cartilagenous structures or for regions that 
contain types V or VI collagens. These data indicate that the 
antibody does not recognize any known collagen other than 
type VII. 
Table IL Cross-reactivity of  the Anti-type VII 
Collagen Monoclonal Antibody with Other Collagen Types 
Determined  by ELISA 
A405 nm* 
Hybridoma  Purified and  Culture 
Collagen type  culture media  diluted ascites  media alone 
I  0.021  0.015  0.011 
II  0.019  0.015  0.013 
III  0.022  0.005  0.007 
IV  0.010  0.023  0.015 
V  0.033  0.012  0.004 
VI  0.025  0.011  0.004 
VII  0.444  0.477  0.034 
* Values are averages of three  independent determinations. 
The Journal of Cell Biology, Volume 103, 1986  1580 Figure 5.  A comparison of indirect immunofluorescent  patterns produced by monoclonal antibodies to type VII and type IV collagens. 
Monoclonal antibodies to type VII collagen specifically direct staining of the dermal-epidermal  junction  basement membrane zone of skin 
and the amniotic epithelial basement membrane of chorioamnion. The location of all basement membrane is indicated by the fluorescence 
directed  by a monoclonal antibody to Type IV collagen (12). Bar, 50 ~tm. 
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Type VII Collagen as Detected by Immunofluorescence 
with Anchoring Fibrils Detected Ultrastructurally 
Anchoring 
Immunofluoreseenee  fibrils  (reference) 
Skin  +  +(4) 
Chorioarnnion  +  +(8) 
Placenta  -  - 
Skeletal muscle  -  - 
Cornea  (Bowman's 
membrane)  +  +(27) 
Oral mucosa  +  +(36) 
Cervix  +  +(23) 
Kidney cortex  -  - 
Lung alveoli  -  - 
Liver sinusoids  -  - 
Stomach (fundus)  -  - 
Large intestine  -  - 
Elastic cartilage  -  - 
1Issue Distribution of  Antigen 
The presence of antigen in foreskin, chorioamnion, placen- 
ta, skeletal muscle, cornea, oral mucosa, cervix, kidney cor- 
tex, lung, liver, stomach, large intestine, and elastic cartilage 
was separately tested by indirect immunofluorescence. As in- 
dicated in Table III, fluorescent staining was observed only 
along the dermal-epidermal  basement  membrane  zone of 
skin,  the  amniotic  epithelial  basement  membrane  zone of 
chorioamnion,  the  epithelial  basement  membrane  of oral 
mucosa and cervix,  and corneal epithelial basement mem- 
brane  but  not Descemet's  membrane.  Kidney,  lung,  liver, 
stomach,  intestine,  and  elastic  cartilage  were  unstained. 
Results  demonstrate  that  there  is  a  direct  correlation  of 
antibody-directed fluorescent staining and the ultrastructural 
observation of anchoring fibrils. 
The ability of various cell types to synthesize type VII col- 
lagen  was  also  analyzed  by  indirect  immunofluorescence. 
Primary  cultures  of amniotic  epithelial  cells  demonstrate 
strong fluorescent staining.  The oral epidermal  carcinoma 
cell  line  KB  (10)  and  the  transformed  epithelial  cell  line 
WISH (15) also show equal intracellular stain intensity (Fig. 
6).  Primary  cultures  of dermal  fibroblasts  are  sometimes 
stained.  Cell  lines  HT  1080  (12),  a  human  fibrosarcoma 
which secretes basement membrane components (1), and FL 
(30),  a  transformed  amniotic  epithelial  cell,  showed  no 
fluorescence when identically treated  (not shown). 
Ultrastructural Immunolocalization of 
g)/pe VII Collagen 
Ultrastructural  immunolocalization of type VII collagen in 
human  skin  was performed  as  described  in Materials  and 
Methods.  Using  a  colloidal  gold-conjugated  second  anti- 
body, metal deposition is detected only in the subbasal lam- 
ina of the dermal-epidermal junction (Fig.  7).  The gold is 
Figure 6. Indirect immunofluorescent  staining of cultured  cells by 
the anti-type VII collagen antibody.  Indirect immunofluorescence 
of KB (c) and WISH (b) cells  in culture,  fixed in acetone and dis- 
playing  intracellular  staining  of type VH collagen.  WISH cells, 
fixed in 2 % paraformaldehyde  (a),  show extracellular  matrix depo- 
sition  of type VII collagen.  Bar,  50 ~tm. 
concentrated within 1.5 ktm of the lamina densa with nearly 
no gold deposited anywhere else within the dermis  or the 
basal cell layer. Deeper regions of the dermis are accessible 
to antibody under the conditions used as shown by deposi- 
tion  of gold  between  matrix  microfibrils  directed  by  an 
anti-microfibril monoclonal antibody (34) (Fig. 8 A). In ad- 
dition, this antibody directed no labeling of anchoring fibrils 
but rather is specific for microfibrils, even though it is of the 
same immunological subtype as the anti-type VII antibody. 
Figure 7. Ultrastructural  immunolocalization of anti-type VII collagen monoctonal antibody to anchoring fibrils.  A monoclonal antibody 
specifically  recognizing the terminal  ends of type VII collagen dimers directs the deposition of colloidal gold to the ends of the anchoring 
fibrils.  Abundant gold deposition was apparent upon the dermal ends of anchoring fibrils  (C and F-K). Less gold was deposited  along 
the lamina densa due to restricted  access of the antibody to that region which is characteristic  of the en bloc technique.  Gold deposits 
are frequently  seen in regions where anchoring fibrils intersect  "amorphous patches" in the dermis (A, B, and D). Banded collagen fibers 
are often seen entrapped within the anchoring fibril arches (A, E, I, and J). B-K are higher magnification  images than A. Bars,  250 nm. 
The Journal of Cell Biology,  Volume 103, 1986  1582 Sakai et al.  Type VII Collagen: the Anchoring  Fibril  1583 Figure 8.  Ultrastructural localization of microfibrillar antigen by the en bloc method and type VII collagen by surface labeling. (A) A 
monoclonal antibody (IgG) to microfibrillar antigen (34) directed 5-nm colloidal gold to microfibrils near the dermal-epidermal junction 
of foreskin, but did not direct label to anchoring fibrils nor to terminal dermal patches. Bar, 250 nm. (B) Anti-type VII directed gold 
label to the entire lamina densa as well as the subbasal lamina when applied to the section surface of Lowicryl K4M-embedded skin, 
followed by 5-nm colloidal gold-conjugated second antibody. Bar, 250 nm. 
No  metal  deposition was  detected in  control experiments 
lacking first antibody (not shown). 
Surface labeling of a  thin  section taken from Lowacryl 
K4M-embedded neonatal foreskin using the anti-type VII 
collagen antibody is shown in Fig. 8 B. With this methodol- 
ogy,  gold deposition is  observed along  the  entire  lamina 
densa of the dermal-epidermal basement membrane in addi- 
tion to regions of the subbasal lamina.  Again,  no labeling 
was observed in the absence of first antibody (not shown). 
Control experiments using antibodies of the same immuno- 
logical subtype, but with specificities not relevant to base- 
ment membrane components, show no gold deposition upon 
the basement membrane, nor within the subbasal lamina (not 
shown). These results clearly show the presence of antigen 
both within the lamina densa and the subbasal lamina. Sur- 
face labeling  has  the disadvantage that  distinct anchoring 
fibrils are difficult to visualize. 
Together,  the  en  bloc  and  surface  labeling  procedures 
demonstrated specific gold labeling of both ends of anchor- 
ing fibrils as predicted by the known location of the epitope 
within type VII collagen and the proposed relationship of 
type VII collagen to anchoring fibrils. 
Gold depositions frequently occurred upon the dermal ter- 
minii of anchoring fibrils as predicted by the known terminal 
location of the epitope in type VII collagen. These dermal 
termini often were seen inserting into an amorphous feltwork 
as previously described (27). These amorphous patches label 
intensely with the antibody.  The sites of labeling of these 
patches coincide with locations of anchoring fibril insertion. 
These studies demonstrate that type VII collagen is located 
in the subbasal lamina of the dermal-epidermal junction of 
skin. The data further demonstrate that the carboxyl terminii 
of anchoring fibrils insert into the lamina densa and extend 
into  the  dermis  as  well,  often  ending  in  an  amorphous 
feltwork. 
Discussion 
The observation of antibody-directed gold deposition upon 
ultrastructurally  identified anchoring  fibrils  using  a  well- 
The Journal of Cell Biology, Volume 103, 1986  1584 Figure 9. The proposed relationship of type VII collagen to anchor- 
ing fibrils. The illustration depicts the known structure of type VII 
collagen (9). In the lower portion of the figure, the three ~t chains 
of each dimeric type VII collagen molecule are shown. Intercon- 
necting lines indicate the sites of disulfide bonds. Dimerization oc- 
curs at the amino-terminal ends of the molecules (9). Fiber forma- 
tion is proposed to occur by unstaggered lateral association of type 
VII collagen dimers (middle portion of the figure). This aggregate 
is proposed to correspond to the banded anchoring fibril. The inter- 
action of type VII collagen (and the anchoring fibril) with the lam- 
ina densa is believed to be mediated by a non-triple helical portion 
of type  VII collagen lost during proteolytic  solubilization. The 
model is consistent with the observed lengths of anchoring fibrils 
and type VII collagen dimers, with the similarity of banding pat- 
terns  of type  VII collagen SLS crystallites and ultrastructurally 
visualized anchoring fibrils, with the tissue distribution of type VII 
collagen and anchoring fibrils, and with the deposition of colloidal 
gold upon anchoring fibrils directed by a type VII-specific mono- 
clonal antibody. 
characterized monoclonal antibody, together with the corre- 
lation of dimensions and banding patterns of type VII colla- 
gen SLS crystallites with those of anchoring fibrils (8),  in 
addition to the exact correlation of tissue distribution and lo- 
cation between type VII collagen and anchoring fibrils, allow 
us to conclude that type VII collagen is a major structural 
component of anchoring fibrils. 
Anti-type VII  collagen-directed gold deposition within 
the subbasal lamina of skin is very often seen over electron- 
dense amorphous patches (see Fig.  7).  While these struc- 
tures have been thought to be undulations of basement mem- 
branes, we and others (27) have observed these materials at 
locations quite distant from the lamina densa. 
The identification of anchoring fibrils as the tissue form 
of type VII collagen suggests that the fiber form of the mole- 
cule  is  an  unstaggered parallel array  of dimeric type VII 
molecules. The anchoring fibril is the first observed collage- 
nous structure which uses this aggregation method in vivo. 
Fig. 9 depicts the proposed relationship of type VII collagen 
dimers to the structure of anchoring fibrils. Attempts to form 
these structures in vitro under physiological conditions have 
thus far failed. The fiber-forming mechanism for type VII 
collagen is likely to involve non-helical domains at the car- 
boxyl termini which are lost during pepsin solubilization of 
the tissue (26). 
The observation of intracellular indirect immunofluores- 
cence of normal and malignant epithelial cells directed by 
type VII-specific antibodies suggests that anchoring fibrils 
are products of the epithelium. Staining of dermal fibroblast 
cultures is occasionally seen, but it is our impression from 
biosynthetic studies of epithelial cells (26) and fibroblasts the 
amount of type VII made by fibroblasts is relatively minor. 
However, these cells can make detectable amounts of both 
types IV and VII collagens (Sakai, L., unpublished observa- 
tions). The extent to which fibroblast products contribute to 
the structure of  the lamina densa or to anchoring fibrils is un- 
known. 
Monoclonal antibodies AF1 and AF2 have been previously 
reported to stain anchoring fibrils (14). However, these anti- 
bodies do not direct staining of fetal human skin before 26 
wk of gestation (24) even though anchoring fibrils can be 
visualized ultrastructurally by 10 wk (17). The antibody we 
have described here specifically stains the fetal dermal-epi- 
dermal junction as early as week 7 of  gestation, as one would 
expect for a major anchoring fibril component (Smith, L., 
unpublished observations). These results suggest that either 
additional  components become associated  with anchoring 
fibrils later in development, or AF1 and AF2 may recognize 
cross-link sites in type VII collagen or specific conforma- 
tions dependent upon a  state of aggregation which occurs 
subsequent to anchoring fibril synthesis and secretion. 
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